CTOs on the Move

Haemonetics

www.haemonetics.com

 
We believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. We seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. Working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right dose to the patient who does.
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion

Executives

Name Title Contact Details
Frank Chan
Executive Vice President & Chief Operating Officer Profile
Anila Lingamneni
Executive Vice President and Chief Technology Officer Profile
Kimberly Weatherbee
Vice President of Information Technology Profile

Funding

Haemonetics raised $700M on 06/18/2018
Haemonetics raised $23M on 05/23/2019
Haemonetics raised $435M on 03/01/2021

Similar Companies

American Medical Supplies

American Medical Supplies is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Denville Scientific

Denville Scientific is a Metuchen, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CardioFocus

CardioFocus is a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF).

Establishment Labs

Establishment Labs is a global, privately held, high-tech medical device and aesthetics company that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast and body shaping implants. With more than 30 years of advanced breast implant manufacturing experience, building quality breast implants has always been a natural outcome for Establishment Labs` founders and top executives. As a result, Motiva Implants® has established a level of product innovation that always results in safety. And while we respect our past, we ́re more focused on the present and the future, one that ́s innovative, safe and progressive. We believe that these goals can be achieved by incorporating the current needs and preferences of plastic surgeons and patients into our product design.

Impedimed

ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. ImpediMed`s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in breast cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm in female breast cancer patients.